Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
THURSDAY, Aug. 17, 2023 -- Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent years, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2023 Category: Pharmaceuticals Source Type: news
VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson
CARY, N.C., Aug. 4, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Daiichi Sankyo, Inc., as a specialty pharmacy provider for VANFLYTA® (quizartinib). VANFLYTA is indicated for use in combination with standard cytarabine an... (Source: McKesson News)
Source: McKesson News - August 4, 2023 Category: Information Technology Source Type: news
FDA approves gilteritinib for relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
On November 28, 2018, the Food and Drug Administration approved gilteritinib (XOSPATA, Astellas Pharma US Inc.) for treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 31, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Leukemia With IKZF ₁ Deletion Benefits From Prolonged Maintenance Therapy
MONDAY, July 31, 2023 -- For children with acute lymphoblastic leukemia (ALL), cases with IKZF ₁ deletion (IKZF₁del) benefit from prolonged maintenance therapy, according to a study published online July 17 in the Journal of Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2023 Category: Pharmaceuticals Source Type: news
FDA approves Daiichi Sankyo's new first-line AML drug quizartinib with boxed warning for heart disorders
Patients with a rarer form of acute myeloid leukemia now have a frontline treatment option for the first time, thanks to the FDA’s approval of Vanflyta (quizartinib), Daiichi Sankyo announced late Thursday. Vanflyta has been approved for FLT3-ITD-positive AML patients in…#myeloid #fda #daiichisankyo #aml #unlock (Source: Reuters: Health)
Source: Reuters: Health - July 21, 2023 Category: Consumer Health News Source Type: news
New Targeted Drug OK'd for Acute Myeloid Leukemia
(MedPage Today) -- The FDA approved quizartinib (Vanflyta) for FLT3 internal tandem duplication (ITD)-positive acute myeloid leukemia (AML), the agency announced on Thursday.
Quizartinib is indicated for newly diagnosed patients in combination... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 21, 2023 Category: Hematology Source Type: news
FDA Approves Vanflyta (quizartinib) for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia
TOKYO& BASKING RIDGE, N.J. July 20, 2023 --(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) today announced that Vanflyta (quizartinib) has been approved by the U.S. Food and Drug Administration (FDA) in combination with standard cytarabine and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 20, 2023 Category: Drugs & Pharmacology Source Type: news
FDA approves quizartinib for newly diagnosed acute myeloid leukemia
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 20, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Quizartinib Boosts AML Survival, Regardless of SCT Quizartinib Boosts AML Survival, Regardless of SCT
Adding quizartinib to standard induction chemotherapy significantly improves overall survival in patients with newly diagnosed acute myeloid leukemia regardless of prior stem cell transplantation.MDedge News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 19, 2023 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news
Spleen Volume Linked to Outcome After HSCT for Leukemia Patients
WEDNESDAY, July 19, 2023 -- For patients with acute myeloid leukemia (AML), higher spleen volume at the time of hematopoietic stem cell transplant (HSCT) is associated with inferior overall survival and an increased incidence of nonrelapse mortality... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 19, 2023 Category: Pharmaceuticals Source Type: news
Aptevo Therapeutics Stock Is Sinking Today - Here's Why
Aptevo Therapeutics Inc APVO announced that its bispecific acute myelogenous leukemia (AML) drug candidate APVO436, in combination with venetoclax and azacitidine, achieved positive duration of remission results in its Phase 1b dose-escalation trial. High response rate observed: 82% (9/11) of…#aml #durationofremission #dor #phase2 #1h24 #apvo (Source: Reuters: Health)
Source: Reuters: Health - July 18, 2023 Category: Consumer Health News Source Type: news
Overweight/Obese BMI Linked to Worse Survival in Young People With Leukemia
THURSDAY, July 13, 2023 -- For adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), overweight/obese body mass index (BMI) is associated with worse outcomes, according to a study published online July 11 in Blood... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2023 Category: Pharmaceuticals Source Type: news
In Defense of Parasocial Relationships
I’ve been juggling parasocial relationships for most of my life. As a newly online kid in the 1990s, I downloaded programs that helped me make fan art featuring my favorite bands: Dashboard Confessional, Something Corporate, and Blink-182. Now, a couple decades later, I refer to these artists by their first names (Chris, Andrew, Mark) to my friends and family and passionately defend them on internet forums. Thanks to TikTok and Instagram, I can tell you with authority what their kitchens look like, what their dogs are named, and what they put in their morning smoothies. Is it any wonder I feel like I know them?
[time...
Source: TIME: Health - July 13, 2023 Category: Consumer Health News Authors: Angela Haupt and Video by Andrew D. Johnson Tags: Uncategorized healthscienceclimate Mental Health Source Type: news
Obesity Associated With Worse Outcomes in Adolescent/Young Adults Treated for ALL
(MedPage Today) -- Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) who are overweight or obese and are treated with asparaginase-containing pediatric regimens, are likelier to have poorer outcomes than those with normal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 12, 2023 Category: Hematology Source Type: news
Obesity, Overweight Shrinks Survival Rates Against Childhood Leukemia
WEDNESDAY, July 12, 2023 -- A growing obesity epidemic may affect the outcome of treatment for those dealing with cancer, according to a new study of adults and teens being treated for acute lymphoblastic leukemia (ALL).
Researchers called for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 12, 2023 Category: General Medicine Source Type: news
